Outset Medical, Inc.
NASDAQ:OMMedical - Devices
+$0.73 today
- Market cap
- $54.86M
- Beta
- 1.94
- P/E (TTM)
- -1.2
- EPS (TTM)
- -$4.07
Volume 0.08M
Average 0.16M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Outset Medical, Inc.
NASDAQ:OM
Intrinsic Alpha fair value
Locked
Current Price
$2.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +1.2% | +10.2% (5yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Recent growth has been strongest in Revenue at +1.2% over three years. Forward estimates point to Revenue at +10.2% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Shoulder Innovations, Inc. NYSE:SI | $432.88M | $20.69 | Not rated | -8.4 | +46.75% |
Viemed Healthcare, Inc. NASDAQ:VMD | $347.48M | $9.17 | Undervalued | 27.4 | +35.59% |
Inogen, Inc. NASDAQ:INGN | $147.95M | $5.69 | Not rated | -7.0 | -17.75% |
Quanterix Corporation NASDAQ:QTRX | $139.11M | $2.93 | Not rated | -1.5 | -65.65% |
Perspective Therapeutics, Inc. AMEX:CATX | $113.89M | $0.94 | Not rated | -0.0 | -63.02% |
Solana Company NASDAQ:HSDT | $101.01M | $1.73 | Not rated | -0.9 | -48.92% |
Tenaya Therapeutics, Inc. NASDAQ:TNYA | $79.59M | $0.35 | Not rated | -1.3 | -74.27% |
Nano-X Imaging Ltd. NASDAQ:NNOX | $25.36M | $0.32 | Not rated | -1.5 | -78.79% |
SANUWAVE Health, Inc. NASDAQ:SNWV | $15.66M | $1.82 | Undervalued | 5.0 | -81.50% |
Continue the stock analysis
Jump to another research area for this company.